Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Journal of Contemporary Brachytherapy|October 23, 2014
High-dose-rate brachytherapy boost for prostate cancer: rationale and techniqueGerard C MortonCancer Management and Research|December 5, 2014
Single fraction radiotherapy versus multiple fraction radiotherapy for bone metastases in prostate cancer patients: comparative effectivenessFrederick Yoon, Gerard C MortonTranslational Andrology and Urology|July 28, 2018
High dose-rate brachytherapy in the treatment of prostate cancerLucas C Mendez, Gerard C MortonBrachytherapy|November 27, 2007
A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapyGerard C Morton, Raxa Sankreacha, Patrick Halina, et al.BJU International|August 5, 2004
Wide variation of prostate-specific antigen doubling time of untreated, clinically localized, low-to-intermediate grade, prostate carcinomaRichard Choo, Laurence Klotz, Gerrit Deboer, et al.Brachytherapy|May 16, 2016
Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancerDeidre L Batchelar, Hans T Chung, Andrew Loblaw, et al.Brachytherapy|December 31, 2010
Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapyRick Holly, Gerard C Morton, Raxa Sankreacha, et al.Cancer Research|February 3, 2006
Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: a well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxiaUrban Emmenegger, Gerard C Morton, Giulio Francia, et al.The Journal of Urology|March 26, 2002
Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progressionRichard Choo, Laurence Klotz, Cyril Danjoux, et al.Nature Reviews. Urology|July 1, 2017
The evolution of brachytherapy for prostate cancerNicholas G Zaorsky, Brian J Davis, Paul L Nguyen, et al.Pageof 2